Provided by Tiger Trade Technology Pte. Ltd.

Norway Government Pension Fund

1,263.235
-13.868-1.09%
Number of Gainers:13
Number of Losers:39
Number of Flat:1
PE:- -
High:1,274.095
Open:1,273.134
Low:1,257.042
Close:1,277.103
Volume:2.39B
Turnover:52.81B
Market Cap:31.61T
Float Cap:20.47T

Loading ...

Transcenta Holding - Grants WuXi Biologics Non-Exclusive License to Hicb Platform and Excelpro Cell Culture Media

THOMSON REUTERS
·
Sep 09

Gateway to Hong Kong: Strategic Meeting Bridges Mainland Enterprises with Global Capital Markets

Deep News
·
Sep 09

Market Chatter: Wharf REIC Reportedly Seals Deal to Sell Last Singapore Property

MT Newswires Live
·
Sep 09

Bilibili Completes Us$500 Million Convertible Senior Notes Offering Due 2031

Reuters
·
Sep 09

CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug

MT Newswires Live
·
Sep 09

Xiaomi-W Allocates HK$50.08 Million to Share Buyback on September 9

Stock News
·
Sep 09

Xiaomi Bought Back 1.9 Mln Class B Shares for HKD50 Mln on Sept 9 - HKEX

THOMSON REUTERS
·
Sep 09

Xiaomi Files HKEX Next-Day Disclosure Return Reporting Share Buyback for Cancellation

Reuters
·
Sep 09

Link REIT Allocates Approximately HK$31.05 Million to Buy Back 800,000 Units on September 9

Stock News
·
Sep 09

Tencent Bought Back 231,000 Shares on Sept 9, HKEX Filing Shows

Reuters
·
Sep 09

Link REIT Files HKEX Next-Day Disclosure Return After Unit Buyback

Reuters
·
Sep 09

Smithfield Falls on Weaker Q3 Outlook

Reuters
·
Sep 09

CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China

Reuters
·
Sep 09

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

Stock News
·
Sep 09

CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection

Stock News
·
Sep 09

CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection

Reuters
·
Sep 09

CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China

THOMSON REUTERS
·
Sep 09

Exclusive-Xiaomi Says Has not Received Any Communication from India Fraud Office, Complies with All Local Laws-Statement

THOMSON REUTERS
·
Sep 09

Exclusive-India Serious Fraud Office Recommends Probe into Xiaomi's India Unit for Alleged Irregularities in Business Model, Foreign Investment Law Compliance-Document

THOMSON REUTERS
·
Sep 09

AI Bubble or a New Era? Charles Li on Why We Should Be Pilots, Not Passengers

Deep News
·
Sep 09